Susan Hasty, Publisher
Table of Contents . . . March 12th, 2001
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in AIDS Weekly | Other Publications
Pathogenesis - Monocytes Harbor HIV During HAART Treatments
Retinitis - Maintenance Treatment Is Unnecessary After Successful HAART
AIDS Therapies - CCR5 Cell Depletion Has Potential For Treatment
AIDS Therapies - Efavirenz Levels Predict Poor Treatment Outcome
Pathogenesis - Specific Immune Response May Underlie Neonatal Resistance to HIV
Quality of Life - Successful HAART Has Few Psychological Benefits
AIDS Therapies - Azodicarbonamide Is Safe, Effective In Preliminary Study
AIDS Therapies - Encouraging 48-Week Protease Inhibitor Resistance Data Reported
AIDS Therapies - Monoclonal Antibodies May Effectively Inhibit HIV
AIDS Therapies - Preliminary Results Presented From Phase III Study Of Tenofovir DF
Blood Testing - International Reference Standards Encouraged
Cervicitis - Successful Treatment Reduces HIV Infection Risk
Disease Progression - High HCV Blood Levels In HIV Patients May Increase Risk Of Developing AIDS
Epidemiology - HIV Infection Rate of Ethiopian Prostitutes at 74%
Lipodystrophy - No Single Antiretroviral Therapy Increases Risk
NewsRx - Drugfacts.Com, NewsRx Collaboration Expands Availability Of Custom Health News For Professionals
Pathogenesis - CD8 Cells Can Prevent CD4+ Cell-Harbored Virus Replication
Pathogenesis - Efficient Integration Is Not Necessary For Efficient Replication
Preventive Medicine - Pregnant Women Need Facts On Transmission Risks
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.